Envestnet Portfolio Solutions Inc. lessened its position in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 16.2% during the second quarter, Holdings Channel reports. The institutional investor owned 41,398 shares of the real estate investment trust’s stock after selling 8,000 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Healthpeak Properties were worth $725,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of DOC. TCTC Holdings LLC raised its position in Healthpeak Properties by 124.3% in the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 751 shares in the last quarter. Brooklyn Investment Group boosted its position in shares of Healthpeak Properties by 198.9% during the 1st quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 873 shares in the last quarter. S.A. Mason LLC boosted its position in shares of Healthpeak Properties by 160.9% during the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust’s stock valued at $30,000 after purchasing an additional 925 shares in the last quarter. Dagco Inc. acquired a new position in shares of Healthpeak Properties in the 1st quarter worth approximately $30,000. Finally, GKV Capital Management Co. Inc. bought a new stake in shares of Healthpeak Properties in the 1st quarter worth approximately $36,000. Institutional investors and hedge funds own 93.57% of the company’s stock.
Healthpeak Properties Trading Up 0.8%
NYSE DOC opened at $18.71 on Tuesday. The firm’s 50 day moving average price is $18.20 and its two-hundred day moving average price is $17.89. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.28 and a current ratio of 1.28. Healthpeak Properties, Inc. has a twelve month low of $16.63 and a twelve month high of $23.26. The stock has a market cap of $13.00 billion, a price-to-earnings ratio of 77.94, a PEG ratio of 3.16 and a beta of 1.09.
Healthpeak Properties Announces Dividend
The firm also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be given a dividend of $0.1017 per share. The ex-dividend date is Friday, December 19th. This represents a c) dividend on an annualized basis and a yield of 6.5%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 508.33%.
Insiders Place Their Bets
In other Healthpeak Properties news, CEO Scott M. Brinker bought 2,930 shares of the company’s stock in a transaction dated Thursday, July 31st. The shares were bought at an average price of $17.06 per share, for a total transaction of $49,985.80. Following the acquisition, the chief executive officer directly owned 210,416 shares of the company’s stock, valued at approximately $3,589,696.96. This trade represents a 1.41% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last 90 days, insiders bought 8,783 shares of company stock worth $150,129. Insiders own 0.23% of the company’s stock.
Analysts Set New Price Targets
A number of brokerages recently weighed in on DOC. Weiss Ratings restated a “hold (c-)” rating on shares of Healthpeak Properties in a report on Wednesday, October 8th. Scotiabank downgraded Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and cut their price objective for the company from $21.00 to $19.00 in a research report on Tuesday, July 29th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $18.00 price objective (down from $28.00) on shares of Healthpeak Properties in a research note on Wednesday, August 20th. Morgan Stanley cut their target price on Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating on the stock in a research report on Friday, August 22nd. Finally, Evercore ISI set a $22.00 target price on Healthpeak Properties in a report on Monday, September 15th. Eight equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $21.33.
Check Out Our Latest Report on Healthpeak Properties
Healthpeak Properties Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles
- Five stocks we like better than Healthpeak Properties
- Using the MarketBeat Dividend Tax Calculator
- Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 High-Yield Banks for Investors to Buy on the Dip
- How Technical Indicators Can Help You Find Oversold Stocks
- 5 Surprising Stocks Set to Benefit From a Future Robotics Boom
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.